ENG and acute lymphoblastic leukemia: The majority of B-ALL and a high proportion of ALL blasts (47.5–98.5%) express Endoglin and the presence of Endoglin increased the leukemogenic potential in vivo as confirmed by Endoglin inhibition using TRC105 [164].